These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention]. Buisson Y Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582 [TBL] [Abstract][Full Text] [Related]
24. Behavior-related risk factors for opisthorchiasis-associated cholangiocarcinoma among rural people living along the mekong river in five greater mekong subregion countries. Songserm N; Charoenbut P; Bureelerd O; Pintakham K; Woradet S; Vanhnivongkham P; Cua LN; Uyen NTT; Cuu NC; Sripa B Acta Trop; 2020 Jan; 201():105221. PubMed ID: 31654901 [TBL] [Abstract][Full Text] [Related]
25. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. Yongvanit P; Pinlaor S; Loilome W J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859 [TBL] [Abstract][Full Text] [Related]
26. Ultrasonography as a tool for monitoring the development and progression of cholangiocarcinoma in Opisthorchis viverrini/ dimethylnitrosamine-induced hamsters. Plengsuriyakarn T; Eursitthichai V; Labbunruang N; Na-Bangchang K; Tesana S; Aumarm W; Pongpradit A; Viyanant V Asian Pac J Cancer Prev; 2012; 13(1):87-90. PubMed ID: 22502719 [TBL] [Abstract][Full Text] [Related]
27. Reinfection by Opisthorchis Viverrini after Treatment with Praziquantel. Saengsawang P; Promthet S; Bradshaw P Asian Pac J Cancer Prev; 2016; 17(2):857-62. PubMed ID: 26925692 [TBL] [Abstract][Full Text] [Related]
28. Update on the risk factors for opisthorchiasis and cholangiocarcinoma in Thailand. Prasopdee S; Rojthongpond T; Chitkoolsamphan Y; Pholhelm M; Yusuk S; Pattaraarchachai J; Butthongkomvong K; Kulsantiwong J; Phanaksri T; Kunjantarachot A; Tesana S; Sathavornmanee T; Thitapakorn V Parasites Hosts Dis; 2023 Nov; 61(4):463-470. PubMed ID: 38043542 [TBL] [Abstract][Full Text] [Related]
30. Plasma Peptidome as a Source of Biomarkers for Diagnosis of Cholangiocarcinoma. Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K Asian Pac J Cancer Prev; 2016; 17(3):1163-8. PubMed ID: 27039742 [TBL] [Abstract][Full Text] [Related]
31. Spatio-Temporal Analysis of Cholangiocarcinoma in a High Prevalence Area of Northeastern Thailand: A 10-Year Large Scale Screening Program. Anchalee N; Thinkhamrop K; Suwannatrai AT; Titapun A; Loilome W; Kelly M Asian Pac J Cancer Prev; 2024 Feb; 25(2):537-546. PubMed ID: 38415540 [TBL] [Abstract][Full Text] [Related]
32. Spatial analysis of cholangiocarcinoma in relation to diabetes mellitus and Opisthorchis viverrini infection in Northeast Thailand. Thinkhamrop K; Suwannatrai K; Kelly M; Suwannatrai AT Sci Rep; 2024 May; 14(1):10510. PubMed ID: 38714779 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692 [TBL] [Abstract][Full Text] [Related]
35. Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms. Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM Cancer Epidemiol; 2012 Apr; 36(2):e89-94. PubMed ID: 22189445 [TBL] [Abstract][Full Text] [Related]
36. The Socioeconomic Burden of Cholangiocarcinoma Associated With Opisthorchis viverrini Sensu Lato Infection in Northeast Thailand: A Preliminary Analysis. Khuntikeo N; Thinkhamrop B; Bundhamcharoen K; Andrews RH; Grundy-Warr C; Yongvanit P; Loilome W; Chamadol N; Kosuwan W; Sithithaworn P; Petney TN Adv Parasitol; 2018; 102():141-163. PubMed ID: 30442308 [TBL] [Abstract][Full Text] [Related]
37. Association of comorbidity between Opisthorchis viverrini infection and diabetes mellitus in the development of cholangiocarcinoma among a high-risk population, northeastern Thailand. Thinkhamrop K; Khuntikeo N; Laohasiriwong W; Chupanit P; Kelly M; Suwannatrai AT PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009741. PubMed ID: 34543283 [TBL] [Abstract][Full Text] [Related]
38. Cholangiocarcinoma protective factors in Greater Mekong Subregion: Critical issues for joint planning to sustainably solve regional public health problems. Songserm N; Woradet S; Kankarn W; Pintakham K; Vanhnivongkham P; Uyen NTT; Cuu NC; Cua LN; Sripa B; Ali A PLoS One; 2022; 17(1):e0262589. PubMed ID: 35085313 [TBL] [Abstract][Full Text] [Related]
39. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. Loilome W; Yooyuen S; Namwat N; Sithithaworn P; Puapairoj A; Kano J; Noguchi M; Miwa M; Yongvanit P Tumour Biol; 2012 Dec; 33(6):2289-98. PubMed ID: 22922884 [TBL] [Abstract][Full Text] [Related]
40. Opisthorchis viverrini Infection Among People in the Border Areas of Three Provinces, Northeast of Thailand. Kaewpitoon SJ; Rujirakul R; Wakkuwattapong R; Matrakool L; Tongtawee T; Panpimanmas S; Pengsaa P; Jomkoa D; Joosiri A; Kaewpitoon N Asian Pac J Cancer Prev; 2016; 17(6):2973-7. PubMed ID: 27356720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]